Growing evidence suggests that urinary and sexual functional outcomes after radical prostatectomy for prostate cancer differ based on race, with Black men experiencing worse outcomes. Alongside efforts to improve quality and equity, incorporating patient-reported outcomes measures into patient care could improve equity in treatment outcomes for men with prostate cancer.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
22 December 2022
A Correction to this paper has been published: https://doi.org/10.1038/s41585-022-00712-z
References
Parry, M. G. et al. Determinants of variation in radical local treatment for men with high-risk localised or locally advanced prostate cancer in England. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-021-00439-9 (2021).
Sanda, M. G. et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl. J. Med. 358, 1250–1261 (2008).
Koelker, M. Racial differences in patient-reported outcomes among men treated with radical prostatectomy for prostate cancer. 6th Annual PROMs Summit “Propelling Equity Through PROMs”. Mass General Brigham https://cpd.partners.org/content/proms-summit-propelling-equity-through-proms (2022).
Flanagin, A. et al. Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA 326, 621–627 (2021).
Cole, A. P. et al. Geographic variability, time trends and association of preoperative magnetic resonance imaging with surgical outcomes for elderly United States men with prostate cancer: a Surveillance, Epidemiology, and End Results-Medicare analysis. J. Urol. 208, 609–617 (2022).
Kim, S. P. et al. Disparities in access to hospitals with robotic surgery for patients with prostate cancer undergoing radical prostatectomy. J. Urol. 189, 514–520 (2013).
Loeb, S. et al. Racial concordance and trust in health communications: a randomized trial of videos about prostate cancer [abstract]. J. Clin. Oncol. 40 (Suppl. 16), 5014 (2022).
Kilbridge, K. L. et al. Lack of comprehension of common prostate cancer terms in an underserved population. J. Clin. Oncol. 27, 2015–2021 (2009).
Gross, M. D., Al Hussein Al Awamlh, B. & Hu, J. C. Assessing treatment-related toxicity using administrative data, patient-reported outcomes, or physician-graded toxicity: where is the truth? Semin. Radiat. Oncol. 29, 333–337 (2019).
Snyder, C., Brundage, M., Rivera, Y. M. & Wu, A. W. A PRO-cision medicine methods toolkit to address the challenges of personalizing cancer care using patient-reported outcomes: introduction to the supplement. Med. Care 57, S1–S7 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.P.C. declares research funding from the American Cancer Society and Pfizer Global Medical Grants. C.M.M. declares funding from Prostate Cancer UK, Movember, the Medical Research Council, Cancer Research UK and the National Institute of Health Research (NIHR); receives fees for HIFU proctoring from SonaCare; has received speaker fees from Astellas and Janssen; and receives research support for photodynamic therapy from Spectracure. M.K. and J.M. declare no competing interests.
Additional information
Rights and permissions
About this article
Cite this article
Cole, A.P., Koelker, M., Makanjuola, J. et al. Can PROMs improve racial equity in outcomes after prostatectomy?. Nat Rev Urol 20, 125–126 (2023). https://doi.org/10.1038/s41585-022-00682-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-022-00682-2
